Opinion

Video

Resources and Education for Operationalizing Bispecifics

Key Takeaways

  • Institutions can utilize specialized training programs and partnerships with biotech firms to address bispecific antibody challenges.
  • Comprehensive regulatory guidance is crucial for navigating the complex approval processes associated with bispecific antibodies.
SHOW MORE

Panelists discuss how infrastructure including specialized staff training, updated protocols, enhanced monitoring systems, and comprehensive educational resources for health care providers is essential for institutions to successfully implement and optimize bispecific antibody therapies while ensuring patient safety and treatment efficacy.

Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
5 experts in this video
5 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.